SDC1 and Sepsis: In addition, the administration of antithrombin preparations and rhTM for sepsis-associated DIC is known to have anticoagulant, anti-inflammatory, and vascular endothelial glycoprotective effects (6–9, 27–30), which may have influenced the blood levels of syndecan-1.